Intrinsic Molecular Subtypes of Breast Cancers Categorized as HER2-positive Using an Alternative Chromosome 17 Probe Assay

Breast Cancer Research - United Kingdom
doi 10.1186/s13058-018-1005-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER–/PR– Breast Cancers, a Chromosome 17 C-HPP Study

Journal of Proteome Research
BiochemistryChemistry
2015English

Identification of New miRNA Biomarkers Associated With HER2-positive Breast Cancers

Oncoscience
Cancer ResearchOncology
2015English

A Phenotypic and Mechanistic Perspective on Heterogeneity of HER2-positive Breast Cancers

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2016English

ZW25 Active in HER2-positive Cancers

Cancer Discovery
Oncology
2018English

Toward an Alternative Intrinsic Probe for Spectroscopic Characterization of a Protein

Journal of Physical Chemistry B
SurfacesTheoretical ChemistryMaterials ChemistryFilmsMedicineCoatingsPhysical
2010English

Intrinsic Subtypes of Breast Cancers Initially Assessed as Probably Benign or of Low Suspicion on Ultrasonography Differ According to Tumor Size

Journal of Ultrasound in Medicine
Nuclear MedicineRadiologyUltrasound TechnologyRadiologicalImagingMedicine
2017English

Impact of an Alternative Chromosome 17 Probe and the 2013 American Society of Clinical Oncology and College of American Pathologists Guidelines on Fluorescence in Situ Hybridization for the Determination of HER2 Gene Amplification in Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Functional Implications of Structural Predictions for Alternative Splice Proteins Expressed in Her2/Neu–Induced Breast Cancers

Journal of Proteome Research
BiochemistryChemistry
2011English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy